PPTA | Immunoglobulin Literature Database
Home
Contact us
- - - - - - -
News/archive
Literature database
Cardiology
Dermatology
Guidelines
Haematology
Infectious Diseases
Internal Medicine
Neonatology
Nephrology
Neurology
Obstetrics
Paediatrics
Pulmonology
Rheumatology
Miscellaneous
PID
Kawasaki disease
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
Kawasaki disease in adult patients.
2
Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy.
3
Kawasaki disease: clinical spectrum of 88 patients in a high-prevalence African-American population.
4
[Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary comp
5
Kawasaki Disease.
6
A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease.
7
Fulminant myocarditis successfully treated with high-dose immunoglobulin.
8
Kawasaki disease with severe cardiac sequelae: Lessons from recent New Zealand experience.
9
Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
10
Review and analysis of 283 cases of Kawasaki disease
11
An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of corona
12
Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatmen
13
Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
14
Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatmen
15
An unusual pattern of arthritis in a child with Kawasaki syndrome.
16
Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
17
A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disea
18
Update on the treatment of Kawasaki disease in childhood.
19
Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globuli
20
A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with a
FIND-ID
Regulators
FDA
EMEA